Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Psoriatic Arthritis”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Testing effectiveness (Phase 2)Looking for participantsNCT07801495
What this trial is testing

Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis

Who this might be right for
Moderate to Severe Psoriatic Arthritis
Novartis Pharmaceuticals 220
Large-scale testing (Phase 3)Study completedNCT01519089
What this trial is testing

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

Who this might be right for
Psoriasis
Pfizer 95
Post-approval studies (Phase 4)Study completedNCT03739853
What this trial is testing

Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial

Who this might be right for
Psoriatic Arthritis
University of Oxford 192
Testing effectiveness (Phase 2)Ended earlyNCT03320876
What this trial is testing

An Open-label, Long-term Extension Study With Filgotinib in Active Psoriatic Arthritis.

Who this might be right for
Psoriatic Arthritis
Lakefront Biotherapeutics NV 122
Large-scale testing (Phase 3)Study completedNCT01365455
What this trial is testing

Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 738
Large-scale testing (Phase 3)Study completedNCT01690299
What this trial is testing

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Who this might be right for
PsoriasisPsoriatic Arthritis
Amgen 250
Large-scale testing (Phase 3)Study completedNCT00747344
What this trial is testing

Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Centocor, Inc. 121
Large-scale testing (Phase 3)Study completedNCT03410992
What this trial is testing

A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque PsoriasisPsoriatic Arthritis
UCB Biopharma SRL 435
Testing effectiveness (Phase 2)Ended earlyNCT00954915
What this trial is testing

Safety Study of the Monoclonal Antibody Teplizumab (MGA031) in Subjects With Moderate or More Severe Psoriasis

Who this might be right for
Psoriasis
MacroGenics 1
Not applicableStudy completedNCT01316224
What this trial is testing

Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment

Who this might be right for
PsoriasisPsoriatic Arthritis
AbbVie (prior sponsor, Abbott) 52
Testing effectiveness (Phase 2)Ended earlyNCT05511519
What this trial is testing

Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Aclaris Therapeutics, Inc. 47
Not applicableLooking for participantsNCT04876781
What this trial is testing

Korean Post-marketing Surveillance for Xeljanz XR

Who this might be right for
Active Moderate to Severe Rheumatoid ArthritisActive Ankylosing SpondylitisActive Psoriatic Arthritis
Pfizer 200
Early research (Phase 1)Looking for participantsNCT06888193
What this trial is testing

Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Who this might be right for
Moderate to Severe Plaque PsoriasisPsoriatic ArthritisAxial Spondyloarthritis+1 more
UCB Biopharma SRL 20
Testing effectiveness (Phase 2)Study completedNCT03101670
What this trial is testing

Assess Efficacy and Safety of Filgotinib in Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Lakefront Biotherapeutics NV 131
Not applicableStudy completedNCT04433442
What this trial is testing

Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis

Who this might be right for
PsoriasisPsoriatic Arthritis
AbbVie 2,324
Large-scale testing (Phase 3)Study completedNCT03357471
What this trial is testing

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

Who this might be right for
Moderate and Severe Active Rheumatoid ArthritisActive Psoriatic ArthritisActive Ankylosing Spondylitis+1 more
UCB Biopharma S.P.R.L. 70
Large-scale testing (Phase 3)Study completedNCT00646178
What this trial is testing

Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy

Who this might be right for
ArthritisPsoriatic
Abbott 102
Testing effectiveness (Phase 2)Study completedNCT01988103
What this trial is testing

Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis

Who this might be right for
PsoriasisPsoriatic ArthritisPsoriasis Arthropatica
Amgen 254
Not applicableStudy completedNCT04541810
What this trial is testing

Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)Atopic Dermatitis (AD)Ankylosing Spondylitis (AS)+1 more
AbbVie 2,369
Testing effectiveness (Phase 2)Active Not RecruitingNCT07148414
What this trial is testing

SPY072 in Rheumatic Disease

Who this might be right for
Rheumatoid ArthritisPsoriatic ArthritisAxial Spondyloarthritis+5 more
Spyre Therapeutics, Inc. 285
Next Page